1. Academic Validation
  2. SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib

SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib

  • Cancer Sci. 2017 May;108(5):1032-1041. doi: 10.1111/cas.13198.
Nobumichi Ohoka 1 Katsunori Nagai 2 Norihito Shibata 1 Takayuki Hattori 1 Hiroshi Nara 2 Nobuo Cho 2 Mikihiko Naito 1
Affiliations

Affiliations

  • 1 Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Setagaya-ku, Tokyo, Japan.
  • 2 Medicinal Chemistry Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Co. Ltd., Fujisawa, Kanagawa, Japan.
Abstract

We previously developed a hybrid small molecule SNIPER (Specific and Nongenetic IAP-dependent Protein ERaser) against transforming acidic coiled-coil-3 (TACC3), SNIPER(TACC3), that induces proteasomal degradation of TACC3 protein. In this study, we found that SNIPER(TACC3) induces cytoplasmic vacuolization derived from endoplasmic reticulum (ER) and paraptosis-like cell death selectively in Cancer cells. Mechanistic analysis suggests that accumulation of ubiquitylated protein aggregates that requires X-linked inhibitor of Apoptosis protein (XIAP) induces ER stress, which results in ER-stress responses involving X-box binding protein-1 (XBP-1) and ER-derived vacuolization in Cancer cells. Importantly, inhibition of Proteasome enhanced the SNIPER(TACC3)-induced vacuolization, and the combination treatment of SNIPER(TACC3) and bortezomib exhibited a synergistic Anticancer activity in several Cancer cell lines. The induction of paraptosis-like cell death in Cancer cells by SNIPER(TACC3) could be applied to treat Cancer cells resistant to undergo Apoptosis by overexpression of XIAP.

Keywords

XIAP; Bortezomib; SNIPER(TACC3); cytoplasmic vacuolization; paraptosis.

Figures
Products